After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
NRIX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Nurix Therapeutics Inc is $1.25B. A total of 1.15 million shares were traded on the day, compared to an average of 762.77K shares.
In the most recent transaction, Ring Christine sold 5,760 shares of NRIX for 19.95 per share on Jan 31 ’25. After the transaction, the Chief Legal Officer now owns 32,538 company shares. In a previous transaction on Jan 31 ’25, CHRISTINE RING bought 5,760 shares at 20.02 per share.
Among the insiders who sold shares, Ring Christine disposed of 3,220 shares on Jan 30 ’25 at a per-share price of $19.85. This resulted in the Chief Legal Officer holding 32,538 shares of NRIX after the transaction. In another insider transaction, Hansen Gwenn sold 3,690 shares at $19.85 per share on Jan 30 ’25. Company shares held by the Chief Scientific Officer now total 55,937.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, NRIX has a high of $29.56 and a low of $10.16.
As of this writing, NRIX has an earnings estimate of -$0.75 per share for the current quarter. EPS was calculated based on a consensus of 13.0 estimates, with a high estimate of -$0.58 per share and a lower estimate of -$0.86.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. NRIX’s latest balance sheet shows that the firm has $295.72M in Cash & Short Term Investments as of fiscal 2021. There were $13.04M in debt and $66.26M in liabilities at the time. Its Book Value Per Share was $6.95, while its Total Shareholder’s Equity was $342.30M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NRIX is Buy with a score of 4.76.
